209 related articles for article (PubMed ID: 26382243)
1. Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.
Ghotbi AA; Sander M; Køber L; Philbert BT; Gustafsson F; Hagemann C; Kjær A; Jacobsen PK
PLoS One; 2015; 10(9):e0138124. PubMed ID: 26382243
[TBL] [Abstract][Full Text] [Related]
2. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.
Sims DB; Mignatti A; Colombo PC; Uriel N; Garcia LI; Ehlert FA; Jorde UP
Europace; 2011 Oct; 13(10):1459-63. PubMed ID: 21551475
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
Rönn F; Kesek M; Karp K; Henein M; Jensen SM
Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
[TBL] [Abstract][Full Text] [Related]
4. Exercise capacity and N-terminal pro-brain natriuretic peptide levels with biventricular vs. right ventricular pacing for atrioventricular block: results from the PREVENT-HF German Substudy.
Stockburger M; de Teresa E; Lamas G; Desaga M; Koenig C; Habedank D; Cobo E; Navarro X; Wiegand U
Europace; 2014 Jan; 16(1):63-70. PubMed ID: 23861381
[TBL] [Abstract][Full Text] [Related]
5. Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy.
Ståhlberg M; Sander M; Mortensen L; Linde C; Braunschweig F
Europace; 2015 Mar; 17(3):439-46. PubMed ID: 25355780
[TBL] [Abstract][Full Text] [Related]
6. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of biventricular pacing on preventing heart failure in patients with high degree atrioventricular block (BIVPACE-AVB Trial)].
Zhang XY; Shan QJ; Su YG; Yan J; Bao ZH; Gu X; Qiu JP; Qin SM; Xu J; Su H; Zhu H; Guo JF; Lu JP; Zou JG; Chen ML; Xu D; Cao KJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):331-7. PubMed ID: 27112612
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.
Gierula J; Cubbon RM; Jamil HA; Byrom R; Baxter PD; Pavitt S; Gilthorpe MS; Hewison J; Kearney MT; Witte KK
Europace; 2013 Nov; 15(11):1609-14. PubMed ID: 23736807
[TBL] [Abstract][Full Text] [Related]
10. Effects of cardiac resynchronization therapy on muscle sympathetic nerve activity.
Kuniyoshi RR; Martinelli M; Negrão CE; Siqueira SF; Rondon MU; Trombetta IC; Kuniyoshi FH; Laterza MC; Nishioka SA; Costa R; Tamaki WT; Crevelari ES; Peixoto Gde L; Ramires JA; Kalil R
Pacing Clin Electrophysiol; 2014 Jan; 37(1):11-8. PubMed ID: 23952584
[TBL] [Abstract][Full Text] [Related]
11. Reevaluating Modality of Cardiopulmonary Exercise Testing in Patients with Heart Failure and Resynchronization Therapy: Relevance of Heart Rate-Adaptive Pacing.
Goldraich L; Ross HJ; Foroutan F; Walker M; Braga J; McDonald MA
J Card Fail; 2017 May; 23(5):422-426. PubMed ID: 28115291
[TBL] [Abstract][Full Text] [Related]
12. The effect of endurance training on exercise capacity following cardiac resynchronization therapy in chronic heart failure patients: a pilot trial.
Conraads VM; Vanderheyden M; Paelinck B; Verstreken S; Blankoff I; Miljoen H; De Sutter J; Beckers P
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):99-106. PubMed ID: 17301634
[TBL] [Abstract][Full Text] [Related]
13. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
14. Survival After Rate-Responsive Programming in Patients With Cardiac Resynchronization Therapy-Defibrillator Implants Is Associated With a Novel Parameter: The Heart Rate Score.
Olshansky B; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Wilkoff BL
Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516461
[TBL] [Abstract][Full Text] [Related]
15. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
16. Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy.
Hardt SE; Yazdi SH; Bauer A; Filusch A; Korosoglou G; Hansen A; Bekeredjian R; Ehlermann P; Remppis A; Katus HA; Kuecherer HF
Int J Cardiol; 2007 Feb; 115(3):318-25. PubMed ID: 16891011
[TBL] [Abstract][Full Text] [Related]
17. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
18. Heart failure study of multipoint pacing effects on ventriculoarterial coupling: Rationale and design of the HUMVEE trial.
Chrysohoou C; Dilaveris P; Antoniou CK; Skiadas I; Konstantinou K; Gatzoulis K; Kallikazaros I; Tousoulis D
Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12510. PubMed ID: 29034563
[TBL] [Abstract][Full Text] [Related]
19. Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing.
Naegeli B; Kurz DJ; Koller D; Straumann E; Furrer M; Maurer D; Minder E; Bertel O
Europace; 2007 Mar; 9(3):194-9. PubMed ID: 17272326
[TBL] [Abstract][Full Text] [Related]
20. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
